Neuropeptide treatment for dry eye and dry mouth syndromes
- 總結
- This technology is a combination of anti-inflammatory neuropeptides for topical treatment of dry eye and dry mouth syndromes.
- 技術優勢
- Oxytocin, secretin, and vasopressin are already available individually as drug treatmentsTreatment targets underlying cause of dry eye and dry mouth syndromesCan be locally delivered to the affected areas (eyes or mouth)Can be formulated as either an aqueous solution or an ointmentCan be used in combination with other pharmaceutical agents
- 技術應用
- Topical treatment of dry eye and dry mouth Treatment for blepharitisTreatment for Sjogren’s syndromeProphylactic treatment of dry eye or dry mouth caused by drug-related side effects or in premenopausal womenCombination therapy with other active pharmaceutical agents for allergy treatmentResearch tool to study the inflammatory pathways in dry eye and dry mouth
- 詳細技術說明
- None
- *Abstract
-
None
- *Inquiry
- Joan MartinezColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- CU13261
- *Principal Investigation
-
- *Publications
- Tech Ventures Reference:IR CU13259, IR CU13261Licensing Contact: Joan Martinez
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
